Cargando…
P1238: EFFICACY ANALYSIS OF PEGASPARGASE, GEMCITABINE, OXALIPLATIN, DEXAMETHASONE COMBINED WITH TISLELIZUMAB IN FIRST-LINE TREATMENT OF PLASMA EBV-DNA POSITIVE EXTRANODAL NK/T CELL LYMPHOMA
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431332/ http://dx.doi.org/10.1097/01.HS9.0000847816.73157.de |
| _version_ | 1784780025429491712 |
|---|---|
| author | Yuan, X. Zhu, Z. Ma, R. Wang, L. Li, H. Jiang, L. Sun, K. |
| author_facet | Yuan, X. Zhu, Z. Ma, R. Wang, L. Li, H. Jiang, L. Sun, K. |
| author_sort | Yuan, X. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431332 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94313322022-08-31 P1238: EFFICACY ANALYSIS OF PEGASPARGASE, GEMCITABINE, OXALIPLATIN, DEXAMETHASONE COMBINED WITH TISLELIZUMAB IN FIRST-LINE TREATMENT OF PLASMA EBV-DNA POSITIVE EXTRANODAL NK/T CELL LYMPHOMA Yuan, X. Zhu, Z. Ma, R. Wang, L. Li, H. Jiang, L. Sun, K. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431332/ http://dx.doi.org/10.1097/01.HS9.0000847816.73157.de Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Yuan, X. Zhu, Z. Ma, R. Wang, L. Li, H. Jiang, L. Sun, K. P1238: EFFICACY ANALYSIS OF PEGASPARGASE, GEMCITABINE, OXALIPLATIN, DEXAMETHASONE COMBINED WITH TISLELIZUMAB IN FIRST-LINE TREATMENT OF PLASMA EBV-DNA POSITIVE EXTRANODAL NK/T CELL LYMPHOMA |
| title | P1238: EFFICACY ANALYSIS OF PEGASPARGASE, GEMCITABINE, OXALIPLATIN, DEXAMETHASONE COMBINED WITH TISLELIZUMAB IN FIRST-LINE TREATMENT OF PLASMA EBV-DNA POSITIVE EXTRANODAL NK/T CELL LYMPHOMA |
| title_full | P1238: EFFICACY ANALYSIS OF PEGASPARGASE, GEMCITABINE, OXALIPLATIN, DEXAMETHASONE COMBINED WITH TISLELIZUMAB IN FIRST-LINE TREATMENT OF PLASMA EBV-DNA POSITIVE EXTRANODAL NK/T CELL LYMPHOMA |
| title_fullStr | P1238: EFFICACY ANALYSIS OF PEGASPARGASE, GEMCITABINE, OXALIPLATIN, DEXAMETHASONE COMBINED WITH TISLELIZUMAB IN FIRST-LINE TREATMENT OF PLASMA EBV-DNA POSITIVE EXTRANODAL NK/T CELL LYMPHOMA |
| title_full_unstemmed | P1238: EFFICACY ANALYSIS OF PEGASPARGASE, GEMCITABINE, OXALIPLATIN, DEXAMETHASONE COMBINED WITH TISLELIZUMAB IN FIRST-LINE TREATMENT OF PLASMA EBV-DNA POSITIVE EXTRANODAL NK/T CELL LYMPHOMA |
| title_short | P1238: EFFICACY ANALYSIS OF PEGASPARGASE, GEMCITABINE, OXALIPLATIN, DEXAMETHASONE COMBINED WITH TISLELIZUMAB IN FIRST-LINE TREATMENT OF PLASMA EBV-DNA POSITIVE EXTRANODAL NK/T CELL LYMPHOMA |
| title_sort | p1238: efficacy analysis of pegaspargase, gemcitabine, oxaliplatin, dexamethasone combined with tislelizumab in first-line treatment of plasma ebv-dna positive extranodal nk/t cell lymphoma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431332/ http://dx.doi.org/10.1097/01.HS9.0000847816.73157.de |
| work_keys_str_mv | AT yuanx p1238efficacyanalysisofpegaspargasegemcitabineoxaliplatindexamethasonecombinedwithtislelizumabinfirstlinetreatmentofplasmaebvdnapositiveextranodalnktcelllymphoma AT zhuz p1238efficacyanalysisofpegaspargasegemcitabineoxaliplatindexamethasonecombinedwithtislelizumabinfirstlinetreatmentofplasmaebvdnapositiveextranodalnktcelllymphoma AT mar p1238efficacyanalysisofpegaspargasegemcitabineoxaliplatindexamethasonecombinedwithtislelizumabinfirstlinetreatmentofplasmaebvdnapositiveextranodalnktcelllymphoma AT wangl p1238efficacyanalysisofpegaspargasegemcitabineoxaliplatindexamethasonecombinedwithtislelizumabinfirstlinetreatmentofplasmaebvdnapositiveextranodalnktcelllymphoma AT lih p1238efficacyanalysisofpegaspargasegemcitabineoxaliplatindexamethasonecombinedwithtislelizumabinfirstlinetreatmentofplasmaebvdnapositiveextranodalnktcelllymphoma AT jiangl p1238efficacyanalysisofpegaspargasegemcitabineoxaliplatindexamethasonecombinedwithtislelizumabinfirstlinetreatmentofplasmaebvdnapositiveextranodalnktcelllymphoma AT sunk p1238efficacyanalysisofpegaspargasegemcitabineoxaliplatindexamethasonecombinedwithtislelizumabinfirstlinetreatmentofplasmaebvdnapositiveextranodalnktcelllymphoma |